POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia
Clinical trial NCT01450514 · COMPLETED
Trial details
- NCT number
- NCT01450514
- Sponsor
- PharmaNeuroBoost N.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-11-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.